MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer
Beiqin Yu(Ruijin Hospital), Bingya Liu(Shanghai Jiao Tong University), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Yingyan Yu(Fujian Medical University), Min Yan(Zhengzhou University), Jianfang Li(Shanghai Jiao Tong University), Liping Su(Guangdong Provincial People's Hospital), Qinlong Gu(Shanghai Jiao Tong University), Xin Lv(Tongji University)
Cited by 71
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298
CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
|Journal of Experimental & Clinical Cancer Research|2019|231
Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell
|World Journal of Gastroenterology|2018|212